Iain Kilty
Director/Miembro de la Junta en Octagon Therapeutics, Inc. .
Cargos activos de Iain Kilty
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Sitryx Therapeutics Ltd.
 Sitryx Therapeutics Ltd. Medical SpecialtiesHealth Technology Sitryx Therapeutics Ltd. Focuses on regulating cell metabolism to develop disease-modifying therapeutics in immuno-oncology and immuno-inflammation. It treats cancer and inflammatory conditions by targeting the metabolism of immune cells. The company was founded by Houman Ashrafian, Paul-Peter Tak, Luke O'Neill, Jonathan Powell, Jeff Rathmell and Michael Rosenblum and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | 01/04/2021 | - |
SV Health Investors LLP
 SV Health Investors LLP Investment ManagersFinance SV Health Investors LLP (SV Health Investors) is a venture capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London. | Inversor de Capital Privado | 01/03/2022 | - |
Octagon Therapeutics, Inc.
 Octagon Therapeutics, Inc. BiotechnologyHealth Technology Octagon Therapeutics, Inc. engages in the research and development of medicines based on novel metabolic targets in disease-causing bacteria, lymphocytes, and cancer cells. It develops a discovery platform that identifies novel therapeutic targets and small molecule inhibitors that are invisible in standard culture conditions. The company was founded by Fred Ausubel, Isaac Stoner, and Shen Yu in 2016 and is headquartered in Allston, MA. | Director/Miembro de la Junta | 01/01/2020 | - |
| Consultor / Asesor | 01/01/2020 | - |
Historial de carrera de Iain Kilty
Antiguos cargos conocidos de Iain Kilty.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Quench Bio, Inc.
 Quench Bio, Inc. BiotechnologyHealth Technology Quench Bio, Inc. develops therapies targeting innate immune pathways to treat life-threatening auto-immune and inflammatory diseases. The company was founded by Mark J. Tebbe, Mike Nolan, and Arturo Zychlinsky and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/01/2019 | 01/04/2021 |
| PFIZER, INC. | Inversor de Capital Privado | 01/03/2013 | 01/01/2019 |
| Partners For Global Research&Development | Inversor de Capital Privado | 01/08/2009 | 01/08/2011 |
Formación de Iain Kilty.
| University of Cambridge | Graduate Degree |
| University of Liverpool | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 5 |
| Reino Unido | 5 |
Operativa
| Private Equity Investor | 3 |
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
Sectorial
| Health Technology | 5 |
| Consumer Services | 3 |
| Finance | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| PFIZER, INC. | Health Technology |
| Empresas privadas | 5 |
|---|---|
SV Health Investors LLP
SV Health Investors LLP Investment ManagersFinance SV Health Investors LLP (SV Health Investors) is a venture capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London. | Finance |
Sitryx Therapeutics Ltd.
Sitryx Therapeutics Ltd. Medical SpecialtiesHealth Technology Sitryx Therapeutics Ltd. Focuses on regulating cell metabolism to develop disease-modifying therapeutics in immuno-oncology and immuno-inflammation. It treats cancer and inflammatory conditions by targeting the metabolism of immune cells. The company was founded by Houman Ashrafian, Paul-Peter Tak, Luke O'Neill, Jonathan Powell, Jeff Rathmell and Michael Rosenblum and is headquartered in London, the United Kingdom. | Health Technology |
Octagon Therapeutics, Inc.
Octagon Therapeutics, Inc. BiotechnologyHealth Technology Octagon Therapeutics, Inc. engages in the research and development of medicines based on novel metabolic targets in disease-causing bacteria, lymphocytes, and cancer cells. It develops a discovery platform that identifies novel therapeutic targets and small molecule inhibitors that are invisible in standard culture conditions. The company was founded by Fred Ausubel, Isaac Stoner, and Shen Yu in 2016 and is headquartered in Allston, MA. | Health Technology |
Quench Bio, Inc.
Quench Bio, Inc. BiotechnologyHealth Technology Quench Bio, Inc. develops therapies targeting innate immune pathways to treat life-threatening auto-immune and inflammatory diseases. The company was founded by Mark J. Tebbe, Mike Nolan, and Arturo Zychlinsky and is headquartered in Cambridge, MA. | Health Technology |
| Partners For Global Research&Development |
- Bolsa de valores
- Insiders
- Iain Kilty
- Experiencia
